• Viewpoint
    Oct. 29, 2024

    The clinical development landscape is rapidly evolving, with hybrid trial approaches and the growing use of RWD/RWE. Clinical trial sponsors are increasingly challenged to manage the vast volume of data generated during multiple, simultaneously running trials.…
  • PEAK Matrix®
    Aug. 19, 2025

    Clinical Data Management (CDM) is rapidly transforming as life sciences enterprises navigate increasing trial complexity, heightened regulatory scrutiny, and the expansion of decentralized and real-world data sources. CDM now plays a strategic role in enabling faster,…
  • Viewpoint
    March 26, 2024

    This report underscores synthetic data’s vital role in addressing data challenges during AI initiatives. It highlights the significance of leveraging synthetic data to train and optimize AI models effectively. Additionally, it explores best practices for using…
  • PEAK Matrix®
    July 22, 2016

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…